Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
643 |
|
| Actual shortage: | 15 (2%) | |
| Anticipated shortage: | 2 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 541 (84%) | |
Discontinuation Reports |
233 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 233 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
80 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE | 2.0MG | TABLET | Resolved | 2017-04-04 | 2017-10-04 | 5338 |
| MYLAN-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-04-07 | 2018-02-15 | 5951 |
| MYLAN-RISPERIDONE | 3.0MG | TABLET | Resolved | 2017-05-04 | 2017-10-03 | 9045 |
| MYLAN-RISPERIDONE | 0.50MG | TABLET | Resolved | 2017-10-23 | 2018-02-15 | 26702 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-10 | 2021-11-23 | 206 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-17 | 2021-11-23 | 3346 |
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-17 | 2021-11-23 | 3360 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-02 | 2021-11-23 | 8719 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-03 | 2021-11-23 | 8764 |
| MYLAN-RIVASTIGMINE PATCH 10 | 18MG | PATCH | Resolved | 2018-03-05 | 2018-04-05 | 41780 |
| MYLAN-RIVASTIGMINE PATCH 10 | 18MG | PATCH | Resolved | 2019-05-08 | 2019-07-30 | 83413 |
| MYLAN-RIVASTIGMINE PATCH 10 | 9.5MG | PATCH | Resolved | 2023-05-31 | 2023-10-03 | 193436 |
| MYLAN-RIVASTIGMINE PATCH 10 | 9.5MG | PATCH | Resolved | 2024-03-25 | 2024-04-16 | 223273 |
| MYLAN-RIVASTIGMINE PATCH 5 | 9MG | PATCH | Resolved | 2018-03-14 | 2018-04-05 | 42873 |
| MYLAN-RIVASTIGMINE PATCH 5 | 9MG | PATCH | Resolved | 2019-05-08 | 2019-07-10 | 83409 |
| MYLAN-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-08-29 | 2017-09-30 | 20575 |
| MYLAN-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-08-29 | 2017-09-30 | 20578 |
| MYLAN-ROSUVASTATIN | 5MG | TABLET | Resolved | 2017-03-10 | 2018-07-05 | 212 |
| MYLAN-ROSUVASTATIN | 10MG | TABLET | Resolved | 2017-11-23 | 2018-04-03 | 30347 |
| MYLAN-ROSUVASTATIN | 40MG | TABLET | Resolved | 2017-11-23 | 2018-06-05 | 30353 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20287 |
| MYLAN-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-07-04 | 20306 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51647 |
| MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-06-06 | 2018-07-04 | 51653 |
| MYLAN-ZOPICLONE | 5MG | TABLET | Discontinued | 2018-05-04 | 2018-05-04 | 48576 |
| MYLAN-ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51665 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51668 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51671 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 5G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51674 |